Everolimus-Induced Pneumonitis in Patients with Neuroendocrine Neoplasms: Real-World Study on Risk Factors and Outcomes

BACKGROUND: Everolimus-induced pneumonitis (EiP) has been poorly studied in patients with neuroendocrine neoplasms (NEN) outside clinical trials. The aim of this study was to evaluate the incidence, risk factors, and outcomes of EiP in patients with NENs using real-world data. METHODS: Retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Taboada, Rodrigo G, Riechelmann, Rachel P, Mauro, Carine, Barros, Milton, Hubner, Richard A, McNamara, Mairéad G, Lamarca, Angela, Valle, Juan W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Gastrointestinal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895743/
https://www.ncbi.nlm.nih.gov/pubmed/35641203
http://dx.doi.org/10.1093/oncolo/oyab024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895743/
https://www.ncbi.nlm.nih.gov/pubmed/35641203
http://dx.doi.org/10.1093/oncolo/oyab024

Ejemplares similares